Expanding Automation Partnerships And AI-Powered Agents Will Drive Business Momentum

Analysts have trimmed their average price targets on UiPath by several dollars, bringing them into a roughly $12 to $17 range. They cited strong Q4 execution and growing AI driven automation use cases, along with valuation compression across software peers and a need for clearer evidence of sustained AI monetization and net new ARR growth.

Analyst Commentary

Recent research paints a mixed picture for UiPath, with most firms trimming price targets but acknowledging solid Q4 execution, progress in AI driven automation, and improving signs around annualized recurring revenue, or ARR. For you as an investor, the key debate centers on how durable ARR growth and AI monetization can be, and how much you want to pay for that while software valuations are compressed.

Bullish Takeaways

• Bullish analysts highlight Q4 as a strong or solid quarter, pointing to beats on ARR and guidance that came in above some expectations. They see this as evidence of better execution.
• Several firms point to accelerating adoption of AI solutions and agentic automation, including traction in AI driven workflows and orchestration products like Maestro, as a potential growth driver if demand continues.
• Comments around stabilization in net new ARR and a more durable growth profile suggest to bullish analysts that the business is moving past earlier volatility. They see this as supportive of current valuations even with lower targets.
• Some bullish analysts also point to potential for organic net new ARR improvement and free cash flow growth over time, supported by vertical go to market efforts and operational changes, as reasons to maintain positive ratings despite target cuts.

Bearish Takeaways

• Bearish analysts focus on the need for clearer evidence of sustained AI monetization and consistent net new ARR growth, noting that constant currency net new ARR is described as roughly flat year over year.
• Several firms cite valuation compression across software peers as a key driver of lower price targets, arguing that UiPath should be priced more conservatively until growth drivers are better proven.
• Some cautious views point to factors such as FX tailwinds, inorganic ARR from the WorkFusion acquisition, and guidance for limited operating margin expansion as reasons the Q4 strength may be less repeatable.
• More cautious research notes that while AI tailwinds and FY27 revenue and ARR guidance are in line or slightly above investor targets, the risk and reward currently look balanced, with upside seen as dependent on stronger organic ARR trends.

What's in the News

• UiPath expanded its collaboration with Deloitte to combine UiPath Test Cloud with Deloitte Ascend. The partnership uses agentic AI to automate software testing tasks and offer self healing execution, with the goal of broader test coverage, faster release cycles, and higher automation ROI for large enterprises. (Key Developments)
• UiPath became a validated technology partner of Databricks, connecting the UiPath Platform with the Databricks platform so enterprises can move from data insights to automated action. The integration includes real time access to trusted data, orchestration of Databricks agents through UiPath Maestro, and governance across AI driven workflows. (Key Developments)
• UiPath Intelligent Xtraction and Processing, or IXP, is now available on Google Cloud Marketplace, with Google Gemini set as the default third party model for new projects. The offering is intended to speed up and improve accuracy in document heavy workflows and support longer, more complex documents. (Key Developments)
• UiPath announced multiple new agentic AI solutions across purchase to pay, financial crime compliance, loan origination, retail and manufacturing workflows, healthcare revenue cycle, and security automation with Microsoft. The solutions are centered on embedding AI agents and orchestration into existing enterprise systems. (Key Developments)
• UiPath issued revenue guidance for fiscal 2027 of US$395 million to US$400 million for Q1 and US$1.754 billion to US$1.759 billion for the full year, and the board authorized a new share repurchase program of up to US$500 million after completing a prior US$1.0 billion buyback covering 80,431,518 shares. (Key Developments)

Valuation Changes

• Fair Value: Model fair value remains unchanged at $13.81, indicating no adjustment in the central valuation estimate.
• Discount Rate: The discount rate is essentially flat, moving marginally from 8.482804% to 8.480616262819693%, a very small reduction.
• Revenue Growth: The revenue growth assumption is stable, with a minimal move from 8.424325% to 8.424325258067555%.
• Net Profit Margin: The net profit margin input is steady, shifting only slightly from 7.168824% to 7.168824368713513%.
• Future P/E: The future P/E multiple is nearly unchanged, edging from 58.802033x to 58.79847530470428x.